latest update:
[RxAtlas]

drug summary · 2 NDC codes

Simlandi

adalimumab-ryvk

HUMAN PRESCRIPTION DRUG record from the RxAtlas dataset, marketing status BLA. Facts and NDC codes below are exported values from the current release, not inferred or edited prose.

dataset id 55137NDC codes 2application BLA761299RxCUI —

Facts

Field definitions, types, and provenance rules are in the data dictionary.

generic nameadalimumab-ryvk
active ingredientsnot reported
dosage formKIT
routenot reported
strengthnot reported
marketing statusBLA
DEA schedulenot reported
application numberBLA761299
ATC codenot reported
RxCUInot reported
manufacturerTeva Pharmaceuticals USA, Inc.
product typeHUMAN PRESCRIPTION DRUG
pharmacologic classnot reported

NDC codes

2 National Drug Codes are mapped to this product in the current release. Package descriptions are not part of the published export, so the NDC code is the canonical package identifier here.

NDCPackage description
51759-386—
51759038622—

Other adalimumab-ryvk products

One other product in the current release publishes the same generic name. Strength, dosage form, and labeler are what distinguish them.

  • Simlandi
    KIT · Teva Pharmaceuticals USA, Inc.

Work with this record

  • Field definitions

    Types, scope, and provenance rules for every exported field.

  • REST API

    Query the same gate-backed records programmatically.

  • Evaluation sample

    Download a bounded slice before buying.

  • $29 API Pass

    Seven days of REST and MCP access to the full catalogue; credited toward the licence.